Sitemap

The most commonly prescribed form of injectable testosterone in the US, known for its long half-life and consistent blood level maintenance.

A widely used injectable testosterone ester with pharmacokinetics very similar to cypionate, popular globally for TRT protocols.

A daily-applied transdermal gel that delivers testosterone through the skin, ideal for patients who prefer non-injectable options.

Estradiol-based therapy for feminizing hormone effects, available as pills, patches, or injections for transgender women and non-binary individuals.

Testosterone therapy for masculinizing effects, used by transgender men and non-binary individuals seeking virilization.

Medications that block or reduce the effects of androgens, commonly used alongside estrogen in feminizing hormone therapy.

The primary treatment for menopausal symptoms, combining estrogen with progesterone to relieve hot flashes, night sweats, and other symptoms.

Hormones molecularly identical to those naturally produced by the body, available in FDA-approved and compounded formulations.

Estradiol patches that deliver consistent hormone levels through the skin, with a potentially lower risk profile than oral estrogen.

The standard first-line treatment for hypothyroidism, providing synthetic T4 hormone to restore normal thyroid function.

Synthetic T3 thyroid hormone used alone or in combination with T4 for patients who do not fully convert T4 to T3.

Porcine-derived thyroid extract containing both T4 and T3, preferred by some patients for its natural hormone profile.

A selective estrogen receptor modulator (SERM) that stimulates ovulation and is often the first-line fertility treatment.

An aromatase inhibitor increasingly used as first-line ovulation induction, particularly effective for women with PCOS.

FSH and LH injections for controlled ovarian stimulation, used in IUI and IVF protocols.

A GLP-1 receptor agonist that has revolutionized medical weight loss, producing average weight loss of 15-17% of body weight.

A dual GIP/GLP-1 receptor agonist showing the highest weight loss results of any medication, with average losses exceeding 20%.

An established daily GLP-1 receptor agonist for weight management, producing moderate but consistent weight loss results.

Recombinant human growth hormone (rhGH) for age-related GH decline, targeting body composition, energy, and recovery.

Dehydroepiandrosterone supplementation to address age-related decline in this precursor hormone for testosterone and estrogen.

Growth hormone secretagogues and other bioactive peptides used to stimulate natural GH production and promote cellular rejuvenation.